Review Article

Post-Autologous (ASCT) Stem Cell Transplant Therapy in Multiple Myeloma

Figure 5

Kaplan-Meier curves for PFS from the landmark of starting consolidation therapy according to the presence or absence of cytogenetic abnormalities. The figure shows PFS for patients with no cytogenetic abnormality or with del(13q) positivity but lack of t(4; 14) and del(17p) or t(4; 14) and/or del(17p) positivity which received VTD consolidation therapy (a) or TD consolidation therapy (b). value according to log-rank test (adapted from [17]).
(a)
(b)